Your browser doesn't support javascript.
loading
Antinuclear antibodies in individuals with COVID-19 reflect underlying disease: Identification of new autoantibodies in systemic sclerosis (CDK9) and malignancy (RNF20, RCC1, TRIP13).
Bossuyt, Xavier; Vulsteke, Jean-Baptiste; Van Elslande, Jan; Boon, Lise; Wuyts, Greet; Willebrords, Silke; Frans, Glynis; Geukens, Nick; Carpentier, Sebastien; Tejpar, Sabine; Wildiers, Hans; Blockmans, Daniel; De Langhe, Ellen; Vermeersch, Pieter; Derua, Rita.
Afiliación
  • Bossuyt X; Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium; Clinical and Diagnostic Immunology, Department of Microbiology, Immunology and Transplantation, KU, Leuven, Belgium. Electronic address: Xavier.bossuyt@uzleuven.be.
  • Vulsteke JB; Department of Development and Regeneration, Skeletal Biology and Engineering Research Center, KU Leuven, Belgium; Rheumatology, University Hospitals Leuven, Leuven, Belgium.
  • Van Elslande J; Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.
  • Boon L; Clinical and Diagnostic Immunology, Department of Microbiology, Immunology and Transplantation, KU, Leuven, Belgium.
  • Wuyts G; Clinical and Diagnostic Immunology, Department of Microbiology, Immunology and Transplantation, KU, Leuven, Belgium.
  • Willebrords S; Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.
  • Frans G; Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.
  • Geukens N; KU Leuven, PharmAbs: The KU Leuven Antibody Center, Herestraat 49 Box 820, 3000 Leuven, Belgium.
  • Carpentier S; SyBioMa, KU Leuven, Belgium.
  • Tejpar S; Laboratory of Molecular Digestive Oncology, Department of Oncology, KU Leuven, Leuven, Belgium; Department of Gastroenterology, University Hospitals Leuven, Belgium.
  • Wildiers H; Department of General Medical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Blockmans D; General Internal Medicine, University Hospitals Leuven, Leuven, Belgium.
  • De Langhe E; Department of Development and Regeneration, Skeletal Biology and Engineering Research Center, KU Leuven, Belgium; Rheumatology, University Hospitals Leuven, Belgium.
  • Vermeersch P; Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium; Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
  • Derua R; SyBioMa, KU Leuven, Belgium; Department of Cellular and Molecular Medicine, Laboratory of Protein Phosphorylation and Proteomics, KU Leuven, Belgium.
Autoimmun Rev ; 22(4): 103288, 2023 Apr.
Article en En | MEDLINE | ID: mdl-36738952
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Enfermedades Autoinmunes / COVID-19 / Neoplasias Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Autoimmun Rev Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Enfermedades Autoinmunes / COVID-19 / Neoplasias Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Autoimmun Rev Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article